---
title: Citation
layout: default
nav_order: 9
---

# **Citation**

## TME deconvolution

Please cite the following papers appropriately for TME deconvolution algorithm if used:

**CIBERSORT**: Newman, A. M., Liu, C. L., Green, M. R., Gentles, A. J., Feng, W., Xu, Y., … Alizadeh, A. A. (2015). Robust enumeration of cell subsets from tissue expression profiles. Nature Methods, 12(5), 453–457. https://doi.org/10.1038/nmeth.3337

**ESTIMATE**: Vegesna R, Kim H, Torres-Garcia W, …, Verhaak R.* (2013). Inferring tumour purity and stromal and immune cell admixture from expression data. Nature Communications 4, 2612. http://doi.org/10.1038/ncomms3612

**quanTIseq**: Finotello, F., Mayer, C., Plattner, C., Laschober, G., Rieder, D., Hackl, H., …, Sopper, S.* (2019). Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome medicine, 11(1), 34. https://doi.org/10.1186/s13073-019-0638-6

**IPS**: P. Charoentong et al.* , Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade. Cell Reports 18, 248-262 (2017). https://doi.org/10.1016/j.celrep.2016.12.019

**MCPCounter**: Becht, E., Giraldo, N. A., Lacroix, L., Buttard, B., Elarouci, N., Petitprez, F., … de Reyniès, A*. (2016). Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biology, 17(1), 218. https://doi.org/10.1186/s13059-016-1070-5

**EPIC**: Racle, J., de Jonge, K., Baumgaertner, P., Speiser, D. E., & Gfeller, D*. (2017). Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data. ELife, 6, e26476. https://doi.org/10.7554/eLife.26476

**Deside**: Xiong X, Liu Y, Pu D, Yang Z, Bi Z, Tian L, Li X. DeSide: A unified deep learning approach for cellular deconvolution of tumor microenvironment. Proc Natl Acad Sci U S A. 2024 Nov 12;121(46):e2407096121. doi: 10.1073/pnas.2407096121. Epub 2024 Nov 8. PMID: 39514318; PMCID: PMC11573681.

## TME Signatures

For signature score estimation, please cite corresponding literature below:

**ssgsea**: Barbie, D.A. et al (2009). Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature, 462(5):108-112.

**gsva**: Hänzelmann, S., Castelo, R. and Guinney, J. (2013). GSVA: Gene set variation analysis for microarray and RNA-Seq data. BMC Bioinformatics, 14(1):7.

**zscore**: Lee, E. et al (2008). Inferring pathway activity toward precise disease classification. PLoS Comp Biol, 4(11):e1000217.